Literature DB >> 18241049

Dopamine D2(High) receptors on intact cells.

Philip Seeman1.   

Abstract

In humans, behavioral dopamine supersensitivity occurs in schizophrenia and in Parkinson's disease. In animals, behavioral dopamine supersensitivity is consistently associated with increased dopamine D2(High) receptors in homogenized striata in vitro. Because D2(High) receptors have not yet been detected in intact cells, we used [(3)H]domperidone to detect D2(High) sites in intact rat anterior pituitary adenoma culture cells. Although [(3)H]raclopride and [(3)H]spiperone did not detect D2(High) receptors in intact cells or in rat fresh striatal slices, [(3)H]domperidone readily detected D2(High) receptors, warranting an in vivo search for D2(High) variations in human diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241049     DOI: 10.1002/syn.20499

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  13 in total

1.  Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.

Authors:  Mette Skinbjerg; Yoon Namkung; Christer Halldin; Robert B Innis; David R Sibley
Journal:  Synapse       Date:  2009-06       Impact factor: 2.562

Review 2.  Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Authors:  Jan-Peter van Wieringen; Jan Booij; Vladimir Shalgunov; Philip Elsinga; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

Review 3.  Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?

Authors:  Mette Skinbjerg; David R Sibley; Jonathan A Javitch; Anissa Abi-Dargham
Journal:  Biochem Pharmacol       Date:  2011-09-16       Impact factor: 5.858

4.  Domperidone as an unintended antipsychotic.

Authors:  Jack Ferrier
Journal:  Can Pharm J (Ott)       Date:  2014-03

5.  Convenient synthesis of 18F-radiolabeled R-(-)-N-n-propyl-2-(3-fluoropropanoxy-11-hydroxynoraporphine.

Authors:  Anna W Sromek; Shaohui Zhang; Vamsidhar Akurathi; Alan B Packard; Wei Li; David Alagille; Thomas J Morley; Ronald Baldwin; Gilles Tamagnan; John L Neumeyer
Journal:  J Labelled Comp Radiopharm       Date:  2014-11-17       Impact factor: 1.921

6.  Synthesis and Evaluation of Fluorinated Aporphines: Potential Positron Emission Tomography Ligands for D2 Receptors

Authors:  Anna W Sromek; Yu-Gui Si; Tangzhi Zhang; Susan R George; Philip Seeman; John L Neumeyer
Journal:  ACS Med Chem Lett       Date:  2011-03-10       Impact factor: 4.345

7.  Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.

Authors:  Ivonne Suridjan; Pablo Rusjan; Jean Addington; Alan A Wilson; Sylvain Houle; Romina Mizrahi
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

Review 8.  Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.

Authors:  Georges Vauquelin; Sophie Bostoen; Patrick Vanderheyden; Philip Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-14       Impact factor: 3.000

Review 9.  Neurocomputational models of basal ganglia function in learning, memory and choice.

Authors:  Michael X Cohen; Michael J Frank
Journal:  Behav Brain Res       Date:  2008-10-04       Impact factor: 3.332

10.  Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms.

Authors:  M J Frank; K Hutchison
Journal:  Neuroscience       Date:  2009-04-22       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.